CD38 and systemic lupus erythematosus: T-bet, RUNX3, and EOMES are attenuated in CD8 + CD38 + T cells from SLE patients, resulting in a decrease in CD8 T cell-mediated cytotoxicity and an increase in susceptibility to infection [47].